Photocure $PHO.OL boost on chinese partnership deal
Photocure 
PHO today released news of a outlicensing of the Cevira franchise for commercialization, giving the stock a boost, possibly regaining foothold above the SMA50 and SMA200.
Press release
https://photocure.com/news/photocure-and-asieris-enter-into-a-global-licensing-deal-for-cevira-with-up-to-usd-250-million-in-milestones-and-double-digit-royalties/
PHO today released news of a outlicensing of the Cevira franchise for commercialization, giving the stock a boost, possibly regaining foothold above the SMA50 and SMA200.Press release
https://photocure.com/news/photocure-and-asieris-enter-into-a-global-licensing-deal-for-cevira-with-up-to-usd-250-million-in-milestones-and-double-digit-royalties/
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.